Component: (Network and Table)
Network
00100 - Statement - Consolidated Balance Sheets
(http://www.genomichealth.com/role/StatementConsolidatedBalanceSheets)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0001131324 (http://www.sec.gov/CIK)
Consolidated Balance SheetsPeriod [Axis]
2016-12-31
2015-12-31
Consolidated Balance Sheets
 
 
ASSETS
 
 
Current assets:
 
 
Cash and cash equivalents
40,404,000  
32,533,000  
Short-term marketable securities
56,585,000  
62,410,000  
Accounts receivable (net of allowance for doubtful accounts; 2016—$4,508, 2015—$3,988)
35,179,000  
37,164,000  
Prepaid expenses and other current assets
13,796,000  
10,843,000  
Total current assets
145,964,000  
 
142,950,000  
 
Property and equipment, net
45,688,000  
39,746,000  
Other assets
9,462,000  
1,921,000  
Total assets
201,114,000  
 
184,617,000  
 
LIABILITIES AND STOCKHOLDERS' EQUITY
 
 
Current liabilities:
 
 
Accounts payable
2,864,000  
8,585,000  
Accrued compensation and employee benefits
27,900,000  
22,239,000  
Accrued license fees
 
2,287,000  
Accrued expenses and other current liabilities
10,180,000  
8,922,000  
Deferred revenues
 
431,000  
Other current liabilities
231,000  
208,000  
Total current liabilities
41,175,000  
 
42,672,000  
 
Other liabilities
3,834,000  
2,410,000  
Commitments and contingencies
xsi:nil  
xsi:nil  
Stockholders' equity:
 
 
Preferred stock, $0.0001 par value, 5,000,000 shares authorized, no shares issued and outstanding
xsi:nil  
xsi:nil  
Common stock, $0.0001 par value; 100,000,000 shares authorized, 34,893,329 and 33,861,759 shares issued and 33,831,998 and 32,800,428 shares outstanding at December 31, 2016 and 2015, respectively
3,000  
3,000  
Additional paid- in capital
427,102,000  
395,059,000  
Accumulated other comprehensive income
1,198,000  
2,752,000  
Accumulated deficit
(242,088,000) 
(228,169,000) 
Treasury stock, at cost, 1,061,331 shares at December 31, 2016 and 2015
(30,110,000) 
(30,110,000) 
Total stockholders' equity
156,105,000  
 
139,535,000  
 
Total liabilities and stockholders' equity
201,114,000  
 
184,617,000